Skip to main content

2. Asthma Diagnosis

The diagnosis of asthma is clinical. Asthma is defined by:

  • Chronic recurrent respiratory symptoms (coughing, wheezing, chest tightness, shortness of breath)

  • Variable airflow limitation (evidenced in spirometry or, peak flow) in children > 5 years of age

  • Reversibility of airflow limitation

  • Exclusion of alternate diagnoses
  • The following definitions of airflow obstruction based on spirometry are below:

Asthma Predictive Index


The modified Asthma Predictive Index (API) is a useful tool to for health care professionals to predict which children may develop asthma in later childhood. 

The API was designed to be used in children under the age of three years old.  

Modified API is only applicable in children with 4 or more wheezing episodes. A positive modified API is when there are 1 or more major criteria OR 2 or more minor criteria in a child with 4 or more wheezing episodes. A positive modified APO is >98% specific for an asthma diagnosis by age 11.

Major Criteria

  • History of asthma in parent(s)

  • MD diagnosed eczema

  • Aeroallergen sensitization

Minor Criteria

  • Wheezing unrelated to colds

  • Eosinophils > 4% on CBC with diff

  • Food allergy to milk, egg, peanuts

Methacholine Challenge Test

The methacholine challenge is a bronchoprovocation test.

  • Bronchoprovocation test

  • Useful when the diagnosis of asthma is in question

  • Historical definition of a positive methacholine challenge was when FEVdecreases more than 20% with inhaled agent or the PC20, the provocation concentration causing a 20% decline in FEV1.

  • 2017 European Respiratory Society Technical Standards recommended a shift from using 20% change to PD20 the provocation dose resulting in a 20% decline FEV1 to calculate level of airway hyperresponsiveness. See table below.

  • Sensitivity 100%, specificity near 50%

PD20 (Micrograms)

Level of airway hyperresponsiveness

>400 Normal
100-400 Borderline
25-100 Mild
6-25 Moderate
<6 Marked